Posts made in February, 2012

Cancer Pathways Are Just One Tool To Managing Cost

Posted on Wednesday, February 29, 2012

According to the Medco Drug Trend report, by 2015 oncology drug costs will be the second or third costliest class that it tracks, up from seventh in 2011.  That’s why, in this relatively unmanaged category,...

Learn More

The Healthcare Round-Up: 2/21- 2/28

Posted on Tuesday, February 28, 2012

Weight-loss drug gets advisory committee nod: Can the benefits of weight-loss outweigh the potential costs of severe medical side-effects? An FDA Advisory Committee thinks so. On Wednesday February 22, the...

Learn More

The Healthcare Round-up: 2/14 -2/21

Posted on Tuesday, February 21, 2012

Payers, technology providers, and policy experts are convening in Las Vegas for the annual HIMSS fest to discuss how IT will enable new delivery models and payment reforms that are supposed to improve quality...

Learn More

So We’re All Wrong About NICE?

Posted on Friday, February 17, 2012

It seems the National Institute of Clinical Excellence (NICE), referred to interchangeably as “cost-watchdog” and “fourth hurdle”, has been woefully misunderstood. The health...

Learn More

The Healthcare Round-up: 2/7 -2/13

Posted on Tuesday, February 14, 2012

What’s better than a box of chocolates or a dozen fair trade, organic red roses? A #healthpolicyvalentine. It’s cheaper too. Wonks and journos quickly embraced the nerdy Twitter hash tag created last week by...

Learn More

The Healthcare Round-Up: 1/31 – 2/6

Posted on Tuesday, February 7, 2012

Every week Real Endpoints scours the web, the wires, and (sometimes) the weeds for the top reimbursement related news you need to know now. Below are our top picks for the past week. ExpressScripts/Medco: Who...

Learn More